Agoracom Blog Home

Archive for the ‘Marijuana Company of America’ Category

Canada to Open More Than 100 Pot Shops as It Becomes the Second Country to Legalize Marijuana $BOG.ca $NBUD.ca $MCOA $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 2:26 PM on Thursday, October 11th, 2018

  • On Oct. 17, Canada becomes the second and largest country with a legal national marijuana marketplace. Uruguay launched legal sales last year, after several years of planning.
  • It’s a profound social shift promised by Canadian Prime Minister Justin Trudeau and fueled by a desire to bring the black market into a regulated, taxed system after nearly a century of prohibition.

(DELTA, British Columbia) — Mat Beren and his friends used to drive by the vast greenhouses of southern British Columbia and joke about how much weed they could grow there.

Years later, it’s no joke. The tomato and pepper plants that once filled some of those greenhouses have been replaced with a new cash crop: marijuana. Beren and other formerly illicit growers are helping cultivate it. The buyers no longer are unlawful dealers or dubious medical dispensaries; it’s the Canadian government.

On Oct. 17, Canada becomes the second and largest country with a legal national marijuana marketplace. Uruguay launched legal sales last year, after several years of planning.

It’s a profound social shift promised by Canadian Prime Minister Justin Trudeau and fueled by a desire to bring the black market into a regulated, taxed system after nearly a century of prohibition.

It also stands in contrast to the United States, where the federal government outlaws marijuana while most states allow medical or recreational use for people 21 and older. Canada’s national approach has allowed for unfettered industry banking, inter-province shipments of cannabis, online ordering, postal delivery and billions of dollars in investment; national prohibition in the U.S. has stifled greater industry expansion there.

Hannah Hetzer, who tracks international marijuana policy for the New York-based Drug Policy Alliance, called Canada’s move “extremely significant,” given that about 25 countries have already legalized the medical use of marijuana or decriminalized possession of small amounts of pot. A few, including Mexico, have expressed an interest in regulating recreational use.

“It’s going to change the global debate on drug policy,” she said. “There’s no other country immediately considering legalizing the nonmedical use of cannabis, but I think Canada will provide almost the permission for other countries to move forward.”

At least 109 legal pot shops are expected to open across the nation of 37 million people next Wednesday, with many more to come, according to an Associated Press survey of the provinces. For now, they’ll offer dried flower, capsules, tinctures and seeds, with sales of marijuana-infused foods and concentrates expected to begin next year.

The provinces are tasked with overseeing marijuana distribution. For some, including British Columbia and Alberta, that means buying cannabis from licensed producers, storing it in warehouses and then shipping it to retail shops and online customers. Others, like Newfoundland, are having growers ship directly to stores or through the mail.

Federal taxes will total $1 per gram or 10 percent, whichever is more. The feds will keep one-fourth of that and return the rest to the provinces, which can add their own markups. Consumers also will pay local sales taxes.

Some provinces have chosen to operate their own stores, like state-run liquor stores in the U.S., while others have OK’d private outlets. Most are letting residents grow up to four plants at home.

Canada’s most populous province, Ontario, won’t have any stores open until next April, after the new conservative government scrapped a plan for state-owned stores in favor of privately run shops. Until then, the only legal option for Ontario residents will be mail delivery — a prospect that didn’t sit well with longtime pot fan Ryan Bose, 48, a Lyft driver.

“Potheads are notoriously very impatient. When they want their weed, they want their weed,” he said after buying a half-ounce at an illicit medical marijuana dispensary in Toronto. “Waiting one or two three days for it by mail, I’m not sure how many will want to do that.”

British Columbia, home of the “B.C. Bud” long cherished by American pot connoisseurs, has had a prevalent marijuana culture since the 1970s, after U.S. draft-dodgers from the Vietnam War settled on Vancouver Island and in the province’s southeastern mountains. But a change in government last year slowed cannabis distribution plans there, too, and it will have just one store ready next Wednesday: a state-run shop in Kamloops, a few hours’ drive northeast of Vancouver. By contrast, Alberta expects to open 17 next week and 250 within a year.

No immediate crackdown is expected for the dozens of illicit-but-tolerated medical marijuana dispensaries operating in British Columbia, though officials eventually plan to close any without a license. Many are expected to apply for private retail licenses, and some have sued, saying they have a right to remain open.

British Columbia’s ministry of public safety is forming a team of 44 inspectors to root out unlawful operations, seize product and issue fines. They’ll have responsibility for a province of 4.7 million people and an area twice as large as California, where the black market still dwarfs the legal market that arrived in January.

Chris Clay, a longtime Canadian medical marijuana activist, runs Warmland Centre dispensary in an old shopping mall in Mill Bay, on Vancouver Island. He is closing the store Monday until he gets a license; he feared continuing to operate post-legalization would jeopardize his chances. Some of his eight staff members will likely have to file for unemployment benefits in the meantime.

“That will be frustrating, but overall I’m thrilled,” Clay said. “I’ve been waiting decades for this.”

The federal government has licensed 120 growers, some of them enormous. Canopy Growth, which recently received an investment of $4 billion from Constellation Brands, whose holdings include Corona beer, Robert Mondavi wines and Black Velvet whiskey, is approved for 5.6 million square feet (520,000 square meters) of production space across Canada. Its two biggest greenhouses are near the U.S. border in British Columbia.

Beren, a 23-year cannabis grower, is a Canopy consultant.

“We used to joke around all the time when we’d go to Vancouver and drive by the big greenhouses on the highway,” he said. “Like, ‘Oh man, someday. It’d be so awesome if we could grow cannabis in one of these greenhouses.’ We drive by now, and we’re like, ‘Oh, we’re here.’”

Next to Canopy’s greenhouse in Delta is another huge facility, Pure Sunfarms, a joint venture between a longtime tomato grower, Village Farms International, and a licensed medical marijuana producer, Emerald Health Therapeutics. Workers pulled out the remaining tomato plants last winter and got to work renovating the greenhouse as a marijuana farm, installing equipment that includes lights and accordion-shaped charcoal vents to control the plant’s odor. By 2020, the venture expects to move more than 165,000 pounds (75,000 kg) of bud per year.

Some longtime illegal growers who operate on a much smaller scale worry they won’t get licensed or will get steamrolled by much larger producers. Provinces can issue “micro-producer” licenses. But in British Columbia, where small-time pot growers helped sustain rural economies as the mining and forestry industries cratered, the application period hasn’t opened yet.

Sarah Campbell of the Craft Cannabis Association of BC said many small operators envision a day when they can host visitors who can tour their operations and sample the product, as wineries do.

Officials say they intend to accommodate craft growers but first need to ensure there is enough cannabis to meet demand when legalization arrives. Hiccups are inevitable, they say, and tweaks will be needed.

“Leaving it to each province to decide what’s best for their communities and their citizens is something that’s good,” said Gene Makowsky, the Saskatchewan minister who oversees the province’s Liquor and Gaming Authority. “We’ll be able to see if each law is successful or where we can do better in certain areas.”

British Columbia safety minister Mike Farnworth said he learned two primary lessons by visiting Oregon and Washington, U.S. states with recreational marijuana. One was not to look at the industry as an immediate cash cow, as it will take time to displace the black market. The other was to start with relatively strict regulations and then loosen them as needed, because it’s much harder to tighten them after the fact.

Legalization will be a process more than a date, Farnworth said.

“Oct. 17th is actually not going to look much different than it does today,” he said.

Source: http://time.com/5421443/canada-legal-marijuana-sales/

Marijuana Company of America $MCOA Applies for Uplisting to OTCQB and Finalizes S1 Registration Statement for Anticipated Equity Financing; Announces New Independent Director and Chief Financial Officer $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 9:00 AM on Thursday, October 11th, 2018

15233 mcoa

  • Announced that the Company filed an application with the OTC Markets on October 3, 2018, to uplist from the OTC Pink to the OTCQB listing tier on the OTC Markets
  • Additionally, the Company is in the process of finalizing a registration statement on Form S-1 that the Company intends to file with the Securities and Exchange Commission (SEC), in conjunction with an anticipated equity line of financing that will allow the Company, once the S-1 is effective, to raise up to $10 million.

Escondido, California–(October 11, 2018) – Marijuana Company of America Inc. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the Company filed an application with the OTC Markets on October 3, 2018, to uplist from the OTC Pink to the OTCQB listing tier on the OTC Markets.

Additionally, the Company is in the process of finalizing a registration statement on Form S-1 that the Company intends to file with the Securities and Exchange Commission (SEC), in conjunction with an anticipated equity line of financing that will allow the Company, once the S-1 is effective, to raise up to $10 million. The Company’s application to uplist to the OTCQB tier is a condition for both the equity line of financing and for the Form S-1 registration statement.

Donald Steinberg, MCOA President and CEO commented: “Our goal is to obtain the necessary capital through our S1 to capitalize on the host of opportunities available in the cannabis and hemp industry right now. Also, moving to a higher OTC Markets reporting tier will help to provide better access to institutional investors, broaden our shareholder base, and provide greater credibility with the Company’s partners, clients, stakeholders, and customers, as well as with the wider investment community.”

The OTCQB tier increases transparency, reporting standards, management certification and compliance requirements. Further, the majority of broker dealers trade stocks on the OTCQB and historically this has resulted in greater liquidity and awareness for companies that reach the OTCQB tier.

On August 31, 2018, the Company engaged Mr. Jesus Quintero as its new Chief Financial Officer, and on September 19, 2018, appointed Robert Coale as an independent director.

Mr. Quintero has served as a financial consultant to several multi-million dollar businesses in South Florida. He has extensive experience in public company reporting and SEC/SOX compliance, and held senior finance positions with Avnet, Inc., Latin Node, Inc., Globetel Communications Corp. and Telefonica of Spain. His prior experience also includes tenure with Price Waterhouse and Deloitte & Touche. Mr. Quintero earned a B.S. in Accounting from St. John’s University and is a certified public accountant.

Mr. Coale brings years of experience in business consulting, private equity investments, financial and strategic joint venture facilitation, including telecommunications, banking, fund raising, non-profit, retirement, entertainment, licensing, gateway interface/merchant processing, real estate development, and strategic planning. Mr. Coale holds a Master’s in Business Administration, with an emphasis on International Marketing and Strategic Planning from Pepperdine University awarded in 1992; a Bachelor of Science with an emphasis in Finance from the University of Southern California awarded in 1982.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com

hempSMART.com

NetworkNewsWires/MCOA

Corporate Communications Contact: 
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Marijuana Company of America $MCOA Appoints Ian Harvey as Global Sales Director of hempSMART(TM) in Preparation of 2019 Launch in Europe $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 9:19 AM on Tuesday, October 9th, 2018

15233 mcoa

  • Company has appointed Ian Harvey as the Global Sales Director of its wholly-owned UK subsidiary hempSMART™, Ltd. in preparation for the Company’s January 2019 product launch in Europe.
  • Under the guidance of Ian Harvey, hempSMART is preparing to launch its successful Network Marketing program and industrial hemp derived Cannabidiol (CBD) product line in Europe in January 2019, starting with the United Kingdom.
  • Pre-registration for the UK is available by visiting www.hempsmart.co.uk.

Escondido, California–(October 9, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the Company has appointed Ian Harvey as the Global Sales Director of its wholly-owned UK subsidiary hempSMART™, Ltd. in preparation for the Company’s January 2019 product launch in Europe.

Under the guidance of Ian Harvey, hempSMART is preparing to launch its successful Network Marketing program and industrial hemp derived Cannabidiol (CBD) product line in Europe in January 2019, starting with the United Kingdom. Pre-registration for the UK is available by visiting www.hempsmart.co.uk.

Ian Harvey has been involved in the direct sales industry for over 35 years. Mr. Harvey has worked for and helped to develop several successful Blue Chip corporations in countries around the world including Japan, South Africa, the United States, and numerous European countries. He has several years of experience launching new product brands, training programs, and implementing strategic approaches designed to capture large networks of loyal customers on an international level.

Donald Steinberg, MCOA CEO, commented, “We are very excited to add Ian Harvey to our hempSMART team. Throughout my career I have successfully launched several companies internationally, and with Mr. Harvey’s experience and hempSMART’s incredible product formulations, I see a unique opportunity to establish and grow our brand to become a household name in Europe and eventually worldwide.”

Ian Harvey commented, “I am extremely excited to be appointed as the Global Sales Director for hempSMART. My goal is to make hempSMART a brand name recognized in households worldwide. It is a great feeling to know many lives will be transformed as we rollout out our expansion plans. Our new Regional support center based in the UK is gearing up to get ready for what is expected to be a massive success story in Europe. We have started our prelaunch in the UK with a vision of being fully launched in January. Once launched, we will then move forward with a very ambitious rollout program to include several European countries along with other Global markets.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Harvest Underway At #Marijuana Company Of America’s $MCOA #CBD Hemp Operation In Scio, Oregon $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 9:40 AM on Tuesday, October 2nd, 2018

15233 mcoa

  • Harvest has begun at the farm
  • Over the next 10 days the team in Scio will harvest this year’s crop, which consists of approximately 36,000 high yielding CBD hemp plants that were grown in an orchard style cultivation on 33 acres

ESCONDIDO, Calif., Oct. 02, 2018  – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, and its joint venture partner Global Hemp Group Inc. (CSE: GHG/ OTC: GBHPF/ FRANKFURT: GHG) (the “Partners”) are pleased to provide an update on their high yielding CBD hemp project in Scio, Oregon.

Harvest
Harvest has begun at the farm. Over the next 10 days the team in Scio will harvest this year’s crop, which consists of approximately 36,000 high yielding CBD hemp plants that were grown in an orchard style cultivation on 33 acres. The team planted six different cultivars this year to determine which would be the optimal hemp variety to grow in the coming year. The team continues to evaluate hemp cultivars that will provide higher CBD yields and a reduced flowering period, which will allow the team to complete the harvest earlier in the year prior to the fall rains.

Preparation for Extraction
Once the hemp is harvested, it will be dried in preparation for storage prior to processing. Drying this season will take place in the project’s four recently completed greenhouses on the farm and will utilize a traditional hanging method, as well as testing an innovative rack drying system. Prior to next season’s harvest, the Partners will construct a permanent drying facility on site. Once the hemp is dried to a 10-12% moisture content, it can be stored with little or no cannabinoid/plant matter degradation, prior to extraction.

Greenhouses
The team has now completed the setup of the first four of five greenhouses, giving the project 15,000+ sq. ft. of active greenhouse space for its drying and cloning operations. A fifth greenhouse (already purchased) will be installed after the drying of this year’s crop is complete. This will increase the active greenhouse space at the project to over 19,000 sq. ft. An additional 20,000 sq. ft. of greenhouse space will be purchased in October as part of further project expansion, with the vision of implementing a year round perpetual harvest model to enhance revenue generation and cash flow, and increasing the size of the cloning operation to be able to supply clones to the local farming community.

The team has now started its cloning operations for the winter crop, which will utilize the current and future greenhouses. Management is exploring opportunities to maximize production by developing beneficial relationships that will help optimize the Project’s profit potential through R&D, data collection and analysis.

Discussions with local Farmers
With the success of this year’s hemp cultivation on display at the farm, it has attracted the attention of the local community and many local farmers that are interested in growing hemp as hemp generates a far greater Return On Investment per acre than any other crop they are currently growing. The Project’s stated goal has been to use 2018 as an initial commercial trial and then to significantly expand the acreage under cultivation in the coming years. Management is currently in discussions with a number of these local farmers regarding contract farming and share cropping for the project, starting next year.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The Company is headquartered in Vancouver, British Columbia, with hemp cultivation operations in New Brunswick and Oregon. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/91c6e0d5-8f9a-4b46-a157-e7d6f6567932
http://www.globenewswire.com/NewsRoom/AttachmentNg/2e31feb6-b422-485b-bef9-7972db707e8c

Marijuana Company of America $MCOA Provides Update on Its Investment in MoneyTrac Technology $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:22 AM on Wednesday, August 29th, 2018

15233 mcoa

  • Announced that it has received 150,000,000 shares of common stock of Global Payout Inc. as part its reverse merger with MoneyTrac Technology
  • Based on the market price of GOHE’s stock on the date of the share issuance, MCOA has a contingent unrealized gain of approximately 700% on its $250,000 investment, subject to future price fluctuations in the market for GOHE’s stock.

Escondido, California–(August 29, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that it has received 150,000,000 shares of common stock of Global Payout Inc. as part its reverse merger with MoneyTrac Technology. Based on the market price of GOHE’s stock on the date of the share issuance, MCOA has a contingent unrealized gain of approximately 700% on its $250,000 investment, subject to future price fluctuations in the market for GOHE’s stock.

On March 13, 2017, MCOA entered into a stock purchase agreement to acquire 15,000,000 common shares of MoneyTrac Technology, Inc., for a total purchase price of $250,000. As part of MoneyTrac’s merger with GOHE, GOHE issued shares from treasury to MCOA on August 24, 2018. On the date of the share issuance, the closing price of GOHE’s stock was $.0116 a share, valuing the 150M shares position at approximately $1,740,000.

Regarding the share issuance, Don Steinberg, President and CEO stated, “We are pleased to announce that we have received a substantial amount of stock in GOHE. Since we are receiving stock in a publicly traded company, we have the opportunity to realize a gain from our investment in MoneyTrac to help provide the Company with capital to help accomplish our aggressive growth goals and business plan in 2018.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Payout, Inc.

Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of comprehensive and customized prepaid payment solutions for domestic and international organizations distributing money worldwide. In 2014, Global introduced its first online payment platform called the Consolidated Payment Gateway (CPG), which allowed its enterprise clients to transfer money to international bank accounts, mobile accounts, and prepaid card accounts. The development of the CPG became the foundation for the introduction of its new, state of the art FINTECH payment system in 2017, for both online and mobile applications to allow account holders to maximize an expanded suite of financial services and minimize operational costs. Global will continue to offer their FINTECH payment system to many vertical markets for support of foreign currency exchange and digital currency, including ongoing support of the banking industry and international governments.

About MoneyTrac Technology

MoneyTrac Technology, Inc. (MTRAC) is a “New Age Technology Holding Company” offering a full-service solution for alternative banking and electronic financial marketplace with technology offerings including Payment Platform, Blockchain, Crypto-Commodity Exchange, Compliance, POS, E-Wallet, Mobile Application and Digital Payment Solutions for businesses and companies in various “high-costs of banking” industries. MTRAC offers additional suites of services ranging from business development, sales and marketing, to digital and print advertisement. We are One Network disrupting the status quo. It is MTRAC’S creative vision to create a “The New Age of Currency™” by bringing innovative technology solutions to various industries and providing the “Key to Cashless™.”

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Senate passes #cannabis legalization bill in final vote #Canada $N.ca $NXTTF $TBP.ca $MCOA

Posted by AGORACOM-JC at 10:16 AM on Wednesday, June 20th, 2018
  • Senate has voted to pass Bill C-45, the government’s legislation to legalize cannabis, meaning that recreational marijuana will soon be legal across Canada
  • Some parliamentarians are calling it an “historic” moment in this country, while others are warning of the work left to be done: raising public awareness about the implications of this incoming major social policy change.

Rachel Aiello, Ottawa News Bureau Online Producer

Published Tuesday, June 19, 2018 4:21PM EDT

Last Updated Wednesday, June 20, 2018 9:45AM EDT

OTTAWA — The Senate has voted to pass Bill C-45, the government’s legislation to legalize cannabis, meaning that recreational marijuana will soon be legal across Canada.

Some parliamentarians are calling it an “historic” moment in this country, while others are warning of the work left to be done: raising public awareness about the implications of this incoming major social policy change.

After more than a year of intensive study in both the House and Senate, the bill cleared the final legislative hurdle Tuesday evening, passing by a vote of 52 to 29 with two abstentions from the Independent Senators from Quebec: Sen. Marie-Françoise Mégie and Sen. Rosa Galvez.

Complete coverage on CTVNews.ca

Sen. Claude Carignan, leader of the opposition in the Senate, speaks to reporters in the Senate foyer on Parliament Hill in Ottawa on Tuesday, June 19, 2018. THE CANADIAN PRESS/Justin Tang

The vote was on a motion from Sen. Peter Harder, the Government Representative in the Senate, to accept the government’s position on the Senate’s amendments and pass the bill as is. It was all that was left in a short round of legislative ping-pong spurred by the upper chamber amending the government legislation.

The House of Commons will be notified of the Senate’s decision. After that, all that is left will be Royal Assent to officially pass the bill and for the government to determine when the new law will come into force.

Leader of the Independent Senators Group Sen. Yuen Pau Woo told reporters after the vote that the mammoth study of Bill C-45 was “a bit of a stress test” for the increasingly Independent Senate.

He said now, the work will have to begin on implementing the legislation, and making sure Canadians understand what this new regime means.

“We are now moving where in the legalized industry we have the chance to push out the illicit elements, we have the chance to do research on cannabis, we have the chance to properly educate our young people on the harms of cannabis use, and all of this should be the focus of the whole country now,” Sen. Woo said.

The legislation — an electoral promise of Prime Minister Justin Trudeau and the Liberal Party –allows adults in Canada to legally possess and use small amounts of recreational cannabis. It sets out parameters around the production, possession, safety standards, distribution, and sale of the drug. It also creates new Criminal Code offences for selling marijuana to minors. The proposed federal law spells out that it will be illegal for anyone younger than 18 to buy pot, but allows for provinces and territories to set a higher minimum age.

In a tweet, Justice Minister Jody Wilson-Raybould, who was the bill’s sponsor, and first introduced the legislation in April 2017, said it was “an historic milestone for progressive policy in Canada.”

The federal government is expected to formally respond to the bill’s passage Wednesday morning in the House of Commons foyer.

Last week, the government announced it would be accepting most but not all of the Senate’s more than 40 proposed amendments to Bill C-45. Among the 13 amendments that the federal Liberals rejected were the proposal to allow the provinces and territories to ban home-grown marijuana, and a proposed change to prohibit pot producers from distributing branded merchandise.

Earlier in the evening, an attempt by Conservative Sen. Claude Carignan to insist on an amendment to let provinces ban marijuana home cultivation, failed.

Reacting to his effort to push back on the government’s rejection of the change, Carignan said his attempt was to give the provinces a right he believes they should have, in an effort to circumvent what is now likely: the matter winding up in court.

Senators spent much of Tuesday offering their final thoughts on the legislation, with some expressing disappointment and frustration over MPs not accepting the Senate’s changes, and raising remaining concerns with the legislation as it stands.

Others argued that the upper chamber had done its due diligence and that it was time to concede to the will of the elected House of Commons, and pass the legislation.

In calling the vote, Senate Speaker George Furey had a slip of the tongue and called “all those in flavour” instead of “all those in favour,” sending snickers through the chamber. “It’s getting late,” Sen. Furey said.

Speaking with reporters following the vote, Sen. Harder said he was finally pausing after the manoeuvrings and the procedural wrangling to acknowledge that after a very lengthy debate, Canada is on the cusp of legalization after nearly a century of prohibition.

“It is a step in the right direction and what we now need to do is to insure as we move forward in implementation, that everybody plays their role, that everybody understands the obligations that they have and uses the opportunity of the next number of weeks to inform themselves of what a legal cannabis market means for them, their family, their communities, and the opportunities and risks that it poses,” said Sen. Harder.

So is marijuana legal? No.

The bill still needs to receive Royal Assent, which is expected as soon as tomorrow. That is the final step — essentially the Crown approving the bill. It’s overseen by Canada’s representative, the Governor General.

Once it passes, the government is expected to declare the date that legalization will come into force and be applicable.

On CTV’s Question Period, parliamentary secretary and the federal government’s point-person on pot, Bill Blair said he expects the date to be some time this September.

That window of time between when the bill passes and when it becomes federal law is to allow for the provinces, territories, municipalities, police forces, and other stakeholders to make sure their piece of the pot pie is operating in accordance with the new rules.

Blair said the date they decide on will be informed by discussions with their provincial and territorial counterparts, which have been given the ability to set regulations in their jurisdictions as to how a legalized marijuana regime will operate.

What you need to know:

Many of the decisions around how legalized marijuana is sold and used will be up to the provinces and territories. Here is what you need to know about what will be allowed:

  • The federally mandated public possession limit of 30 grams of dried cannabis has been maintained across the country, with most jurisdictions opting to keep their legal marijuana-smoking ages in line with those for drinking alcohol.
  • Bill C-45 allows individuals to grow up to four marijuana plants per residence, though some provinces, like Manitoba and Quebec, plan to ban home cultivation.
  • Provincial and territorial plans vary widely on whether you’ll be able to smoke in public.
  • Provinces and territories also differ on whether pot shops will be publicly or privately owned. For those opting for publicly owned stores, these will be operated by provincial Crown corporations that sell liquor. In some cases, provinces have even created subsidiaries of these companies with names. Unless otherwise noted, these will be standalone stores wholly separate from those that sell alcohol.
  • While dried cannabis and cannabis oil — both of which will be sold in 2018 — can be used to make edible products at home, the federal government has said that packaged edible products won’t be commercially available.

For a comprehensive rundown of how each province is approaching legalized marijuana, click here.

Outcome of drug-impaired driving bill pending

Bill C-45 was introduced alongside Bill C-46 which specifically deals with impaired driving. The government has hoped throughout the process that the two bills would pass in close succession.

This legislation proposes changes to the impaired driving laws to give police new powers to conduct roadside intoxication tests, including oral fluid drug tests, and would make it illegal to drive within two hours of being over the legal limit.

However, the Senate amended Bill C-46 to remove the provision that allowed police to conduct random roadside alcohol tests. The Senate also sought to legally downgrade impaired driving offences so that they are not classified as “serious criminality” in order to protect foreign nationals and permanent residents from losing their statuses or becoming inadmissible to Canada after such a conviction.

On Monday, the government gave notice of its position on the Senate changes, stating that it “respectfully disagrees” with these two changes. However, in the motion the government indicates it is willing to accept a handful of other Senate amendments to the legislation.

The House has yet to send this message back to the Senate but once that occurs, Bill C-46 is in for a similar final debate and vote, as seen with Bill C-45, where senators will have to decide whether they insist, or accept and pass the bill.

The House of Commons is scheduled to adjourn for the summer on Friday, June 22, but the Senate is set to sit for a week longer. There is always the potential of an early adjournment, or the opportunity to sit longer in exceptional circumstances.

Source: https://www.ctvnews.ca/politics/senate-passes-cannabis-legalization-bill-in-final-vote-1.3980234

Marijuana Company of America $MCOA Launches New CBD-Infused Cosmetic Product hempSMART(TM) Face $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:34 AM on Tuesday, June 19th, 2018

15233 mcoa

  • Announced that the company’s hempSMART™ brand has launched its revolutionary new cosmetic product, hempSMART™ Face
  • Each bottle of hempSMART™ Face is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (CBD) oil derived from the industrial hemp plant

Escondido, California–(June 19, 2018) – Marijuana Company of America, Inc. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the company’s hempSMART™ brand has launched its revolutionary new cosmetic product, hempSMART Face.

Each bottle of hempSMART Face is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (CBD) oil derived from the industrial hemp plant. The newly developed hempSMART topical is a nourishing facial moisturizer that combines CBD oil with a unique blend of ayurvedic herbs and botanicals that is designed to refresh, replenish, and restore your skin cells on your face.

The innovative new formula is rich in Omega 3, 6, 7 and 9, along with naturally occurring ceramides and contains synergistic ingredients such as Organic Aloe, Sabi Inchi Oil, Argan Kernel Oil, Macademia Seed Oil, Rose Hip Seed Oil, Pomegranate Seed Oil, Tulsi, Turmeric Oil, Frankinsense, Ashwaganda, Sweet Potato Root Extract, Coconut Oil, and Sea Buckthorn Oil.

MCOA’s CEO, Donald Steinberg, commented, “Our team is excited to announce the expansion of the hempSMART brand into the world of cosmetic products. HempSMART will continue to build upon our already established and unique formulations to provide our customers and affiliates with the tools needed to succeed in the wellness industry.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

NNW Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Marijuana Company of America $MCOA Announces the Relaunch of Its Reformulated Patent Pending CBD Product hempSMART(TM) Brain $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:05 AM on Tuesday, June 5th, 2018

15233 mcoa

  • Company’s hempSMART™ brand has relaunched its flagship wellness product hempSMART™ Brain with 10mg of Cannabidiol (CBD) oil per serving
  • Developed to maintain mental clarity, alertness, focus and concentration as well as promote relaxation, restorative sleep, and support the repair and regeneration of brain cells, better known as neurogenesis

Escondido, California–(June 5, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s hempSMART™ brand has relaunched its flagship wellness product hempSMART™ Brain with 10mg of Cannabidiol (CBD) oil per serving.

hempSMART Brain has been relaunched and redesigned with an improved formulation that includes 300mg per bottle of Full Spectrum, non-psychoactive, water soluble CBD oil per serving and contains a botanical blend of all-natural plant-based ingredients such as Ashwaganda, Fulvic Acid, Rhodiola Rosea Extract, Bacopa, L-Theanine, Green Tea Extract, and Huperzia Serrata.

hempSMART Brain has been developed to maintain mental clarity, alertness, focus and concentration as well as promote relaxation, restorative sleep, and support the repair and regeneration of brain cells, better known as neurogenesis. This unique formula promises to revolutionize the safe, effective, and natural optimization of brain wellness.

MCOA‘s CEO Donald Steinberg stated, “After reviewing our hempSMART Brain product, our formulators chose to improve upon the original product by doubling the original dosage of CBD. Our team is proud to be able to welcome our flagship product back onto the market and look forward to the upcoming marketing campaigns.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication, and disclaims CBD as a dietary supplement. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

NNW Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Marijuana Company of America $MCOA and Global Hemp Group $GHG.ca Provide Update on New Brunswick Hemp Project $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:40 AM on Wednesday, May 30th, 2018

15233 mcoa

  • Planting of the seeds on the first 77 acres will be completed this week
  • Remaining 48 acres will be seeded over the next two weeks, once the farmers receive soil test results for this acreage and are able to determine fertilizer requirements for this year’s cultivation

Escondido, California–(May 30, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to provide an update on its 125-acre industrial hemp project in northeast New Brunswick with joint venture partner Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG).

The planting of the seeds on the first 77 acres will be completed this week. The remaining 48 acres will be seeded over the next two weeks, once the farmers receive soil test results for this acreage and are able to determine fertilizer requirements for this year’s cultivation.

The Department of Aquaculture Agriculture and Fisheries (DAAF) will also be conducting fertility trials on reserved plots at participating farms. DAAF will contribute the fertilizers to the project as part of these trials. The trials will be conducted at no cost to the project and are a clear indication of the collaborative relationship that has been established with DAAF.

In addition, there is an organic certification trial underway on an additional two-acre plot at the project. It will take three years to complete the organic certification process for this field. As part of the process, the plot will begin a three-year cultivation rotation of hemp, oats and a green manure crop to be defined at a later date. In three years this plot will produce certified organic CBD and organic oats, a crop with an excellent market.

Project managers are currently evaluating drying equipment that will be required to process the biomass after it is harvested. Drying will prepare the biomass for shipment to processors for extraction of the cannabinoids. Management is in discussions with a number of potential processing partners for this material. A final decision will be made in the coming weeks.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG), is headquartered in Vancouver, British Columbia, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

#Cannabis and #CBD Markets are Set to Increase in Value $N.ca $NXTTF $TBP.ca $MCOA

Posted by AGORACOM-JC at 3:59 PM on Tuesday, May 29th, 2018
  • U.S. medical cannabis market is projected to reach $19.48 billion by 2024
  • Projected growth is driven by the increasing acceptance of medical advantages associated with cannabis, particularly for patients dealing with cancer, diabetes and chronic pain

NEW YORK, May 29, 2018 — According to a report by Hexa Research, the U.S. medical cannabis market is projected to reach $19.48 billion by 2024. The projected growth is driven by the increasing acceptance of medical advantages associated with cannabis, particularly for patients dealing with cancer, diabetes and chronic pain. Symptoms and conditions that may be treated with cannabis products include cancer, HIV, AIDS, Alzheimer’s disease, and multiple sclerosis. Chronic pain accounted for 46 percent of the U.S. cannabis medical market share in 2016. According to the research, the solid cannabis edibles segment in 2016, within the U.S. market generated $2.47 billion in revenue and is expected to continue to dominate the cannabis industry to 2024. Chineseinvestors.com, Inc. (OTC: CIIX), Kush Bottles, Inc. (OTC: KSHB), General Cannabis Corporation (OTC: CANN), Isodiol International Inc. (OTC: ISOLF), PotNetwork Holdings, Inc. (OTC: POTN)

A major portion of the legal cannabis industry Cannabidiol products. Cannabidiol, or CBD, is one of at least 113 active cannabinoids identified in cannabis. The CBD market is growing rapidly in recent years due to CBD’s medical benefits. Sean Murphy, the Founder and Publisher of Hemp Business Journal, said: “Hemp Business Journal estimates the total retail value of all hemp products sold in the U.S. to be at least $688 million for 2016. We estimate the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products. The data demonstrates the hemp industry is growing quickly at 22% five year CAGR and being led by food and body care products, with Hemp CBD products showing a 53% AGR.”

Source: https://www.prnewswire.com/news-releases/cannabis-and-cbd-markets-are-set-to-increase-in-value-683935941.html